GRAL - GRAIL Inc.
NEW YORK, July 28, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminders purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.
LOS ANGELES, July 28, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Grail, Inc. ("Grail" or the "Company") (NASDAQ: GRAL). IF YOU SUFFERED A LOSS ON YOUR GRAIL, INC.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against GRAIL, Inc. (“Grail” or the “Company”) (NASDAQ: GRAL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
SAN FRANCISCO, July 28, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in GRAIL, Inc. (NASDAQ: GRAL) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with substantial losses to submit your losses now . The upcoming lead plaintiff deadline is August 4, 2026.
PHILADELPHIA, July 28, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against GRAIL, Inc. (NASDAQ: GRAL) ("GRAIL" or the "Company") on behalf of investors who purchased or acquired GRAIL common stock during the period from May 13, 2025 through February 19, 2026 (the "Class Period"). Investor Deadline: Investors who purchased or acquired GRAIL common stock during the Class Period may, no later than August 4, 2026 , seek to be appointed as a lead plaintiff representative of the class.
LOS ANGELES, July 28, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Grail, Inc., (“Grail” or the "Company") (NASDAQ: GRAL) investors of a class action on behalf of investors that bought securities between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”). Grail investors have until August 4, 2026 to file a lead plaintiff motion.
Key Dates and Disclosure Events Shareholders Need to Know: From Positive Top-Line Results to a 50.55% Stock Collapse, the Chronology of Grail's NHS-Galleri Trial Reveals an Escalating Pattern of Alleged Investor Harm Key Dates and Disclosure Events Shareholders Need to Know: From Positive Top-Line Results to a 50.55% Stock Collapse, the Chronology of Grail's NHS-Galleri Trial Reveals an Escalating Pattern of Alleged Investor Harm
SAN FRANCISCO, July 28, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in GRAIL, Inc. (NASDAQ: GRAL) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with substantial losses to submit your losses now . The upcoming lead plaintiff deadline is August 4, 2026.
NEW YORK, July 28, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GRAIL, Inc. (NASDAQ: GRAL). Shareholders who purchased shares of GRAL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
A securities fraud class action lawsuit has been filed on behalf of GRAIL investors after its stock plummeted 50% because GRAIL allegedly misled investors relating to GRAIL's NHS-Galleri cancer trial, potentially violating federal securities laws. NEW YORK, July 28, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against GRAIL, Inc. (NASDAQ:GRAL) and certain of the Company's senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.
GRAIL, Inc. Investor Alert: Contact SBS by August 4, 2026 for Opportunity to Lead Securities Fraud Lawsuit PR Newswire
LOS ANGELES, July 28, 2026 /PRNewswire/ -- Schall Brown & Schwartz LLP, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GRAIL, Inc. ("Grail" or "the Company") (NASDAQ: GRAL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. If you purchased GRAIL, Inc. securities you may be entitled to compensation without payment of any out-of-pocket fees or costs.
New York, New York--(Newsfile Corp. - July 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the "Class Period"), of the important August 4, 2026 lead plaintiff deadline. SO WHAT: If you purchased GRAIL common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GRAIL, Inc. (NASDAQ: GRAL) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Grail securities between May 13, 2025 and February 19, 2026, both dates inclusive (the “Class Period”).
Notice to Pension Funds, Asset Managers, and Fiduciaries: Grail's 50.55% Single-Day Collapse Following Failed NHS-Galleri Trial Endpoint May Trigger Fiduciary Review Obligations for Institutional Holders Notice to Pension Funds, Asset Managers, and Fiduciaries: Grail's 50.55% Single-Day Collapse Following Failed NHS-Galleri Trial Endpoint May Trigger Fiduciary Review Obligations for Institutional Holders
SAN FRANCISCO, July 27, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in GRAIL, Inc. (NASDAQ:GRAL) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with substantial losses to submit your losses now . The upcoming lead plaintiff deadline is August 4, 2026.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Grail To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Grail between May 13, 2025 and February 19, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - July 27, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Grail, Inc. ("Grail" or the "Company") (NASDAQ: GRAL) and reminds investors of the August 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti and Auld LLP announces that a class action lawsuit has been filed against GRAIL, Inc. (NASDAQ: GRAL) and certain of the Company's senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.
NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against GRAIL, Inc. (NASDAQ:GRAL) and certain of the Company's senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws. If you invested in GRAIL, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/grail-class-action-lawsuit.
LOS ANGELES, July 27, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against GRAIL, Inc. ("Grail" or "the Company") (NASDAQ: GRAL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of GRAL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.